Literature DB >> 22871079

Speech therapy and communication device: impact on quality of life and mood in patients with amyotrophic lateral sclerosis.

Sonja Körner1, Michael Sieniawski, Michael Siniawski, Katja Kollewe, Klaus Jan Rath, Klaus Krampfl, Antonia Zapf, Reinhard Dengler, Susanne Petri.   

Abstract

Dysarthria has a drastic impact on the quality of life of ALS patients. Most patients suffering from dysarthria are offered speech therapy. Communication devices are prescribed less frequently. In the present study we investigated the impact of these therapeutic arrangements on quality of life in ALS patients. Thirty-eight ALS patients with dysarthria or anarthria, who underwent speech therapy and/or used communication devices answered three standardized questionnaires (Beck Depression Inventory - II (BDI), SF-36 Health Survey questionnaire (SF-36) and ALS Functional Rating Scale-revised (ALSFRS-R)) and were further interviewed about their experience with and benefit of speech therapy and communication devices. Most of the patients described a high impact of the communication device on their quality of life while the influence of speech therapy was rated less. By multiple regression analysis we confirmed an independent positive effect of communication device use on depression and psychological distress. In conclusion, communication systems improve or at least stabilize quality of life and mood in dysarthric ALS patients, and should be provided early in the disease course.

Entities:  

Mesh:

Year:  2012        PMID: 22871079     DOI: 10.3109/17482968.2012.692382

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  15 in total

Review 1.  ALS: Management Problems.

Authors:  Jonathan R Brent; Colin K Franz; John M Coleman; Senda Ajroud-Driss
Journal:  Neurol Clin       Date:  2020-06-11       Impact factor: 3.806

Review 2.  Patient-Perceived Outcomes and Quality of Life in ALS.

Authors:  Zachary Simmons
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

3.  Brain-computer interface (BCI) evaluation in people with amyotrophic lateral sclerosis.

Authors:  Lynn M McCane; Eric W Sellers; Dennis J McFarland; Joseph N Mak; C Steve Carmack; Debra Zeitlin; Jonathan R Wolpaw; Theresa M Vaughan
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-02-20       Impact factor: 4.092

Review 4.  Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis.

Authors:  Sabrina Paganoni; Chafic Karam; Nanette Joyce; Richard Bedlack; Gregory T Carter
Journal:  NeuroRehabilitation       Date:  2015       Impact factor: 2.138

Review 5.  Improving Care in Pediatric Neuro-oncology Patients: An Overview of the Unique Needs of Children With Brain Tumors.

Authors:  Cheryl Fischer; Mary Petriccione; Maria Donzelli; Elaine Pottenger
Journal:  J Child Neurol       Date:  2015-08-05       Impact factor: 1.987

6.  Patient-reported problematic symptoms in an ALS treatment trial.

Authors:  Divisha Raheja; Helen E Stephens; Erik Lehman; Susan Walsh; Chengwu Yang; Zachary Simmons
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2016-01-29       Impact factor: 4.092

7.  Progression and effect of cognitive-behavioral changes in patients with amyotrophic lateral sclerosis.

Authors:  Meredith Bock; Y-Nhy Duong; Anthony Kim; Isabel Allen; Jennifer Murphy; Catherine Lomen-Hoerth
Journal:  Neurol Clin Pract       Date:  2017-12

8.  The Importance of Connection to Others in QoL in MSA and PSP.

Authors:  Louise Wiblin; Rory Durcan; Mark Lee; Katie Brittain
Journal:  Parkinsons Dis       Date:  2017-09-28

9.  Independent home use of a brain-computer interface by people with amyotrophic lateral sclerosis.

Authors:  Jonathan R Wolpaw; Richard S Bedlack; Domenic J Reda; Robert J Ringer; Patricia G Banks; Theresa M Vaughan; Susan M Heckman; Lynn M McCane; Charles S Carmack; Stefan Winden; Dennis J McFarland; Eric W Sellers; Hairong Shi; Tamara Paine; Donald S Higgins; Albert C Lo; Huned S Patwa; Katherine J Hill; Grant D Huang; Robert L Ruff
Journal:  Neurology       Date:  2018-06-27       Impact factor: 11.800

10.  Articulation recovery in ALS patients after lineage-negative adjuvant cell therapy - preliminary report.

Authors:  Wioletta Pawlukowska; Bartłomiej Baumert; Monika Gołąb-Janowska; Ewa Pius-Sadowska; Zofia Litwińska; Maciej Kotowski; Agnieszka Meller; Iwona Rotter; Jarosław Peregud-Pogorzelski; Przemysław Nowacki
Journal:  Int J Med Sci       Date:  2020-07-19       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.